Target intelligence / Profile preview

Redox regulation systems

Molecular classification
Enzyme, Transcription factor, Antioxidant system, Signaling pathway
01

Overview

Redox regulation systems represent a sophisticated network of enzymes, cofactors, and signaling pathways essential for maintaining cellular redox homeostasis and protecting against oxidative damage. The primary components include the thioredoxin (Trx) and glutathione (GSH) systems, which utilize reducing equivalents from NADPH to neutralize reactive oxygen species (ROS) and maintain proteins in their functional reduced states [1, 10]. These systems are dynamically regulated by master transcription factors such as Nrf2, which orchestrates the antioxidant response by inducing the expression of protective enzymes like superoxide dismutase and catalase [1, 8]. In various pathologies, including cancer, neurodegeneration, and chronic inflammation, these systems are often dysregulated; for example, cancer cells frequently upregulate redox defenses to survive high metabolic stress and evade apoptosis [3, 4]. Therapeutic strategies targeting these systems involve either the activation of antioxidant pathways to mitigate tissue damage or the inhibition of redox defenses to selectively sensitize diseased cells to oxidative stress-induced death [2, 14].

Other names
Antioxidant systemsRedox homeostasis systemsCellular redox regulatory networkRedox signaling pathwaysAntioxidant defense system
02

Mechanism of action

Modulation of antioxidant enzyme activity, induction of phase II detoxification enzymes via Nrf2 activation, scavenging of reactive oxygen species (ROS), or depletion of cellular antioxidant capacity to induce oxidative stress-mediated apoptosis.

03

Biological functions

Redox homeostasisOxidative stress responseSignal transductionApoptosisCell survivalMetabolism regulation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationPsychiatric disorderDiabetesInfection
05

Safety considerations

Potential to promote cancer cell survival and therapeutic resistance (antioxidant paradox)Interference with essential physiological ROS signaling (eustress)Off-target effects due to broad modulation of cellular redox stateSystemic toxicity from disrupting redox balance in healthy tissues
06

Interacting drugs

Bardoxolone methyl

8 more in the full profile.

07

Biomarkers

GSH/GSSG ratioMalondialdehyde (MDA)8-hydroxy-2-deoxyguanosine (8-OHdG)Protein carbonylsNrf2 expression levelsThioredoxin levelsReactive oxygen species (ROS) levels

Beyond the preview

Go deeper on Redox regulation systems.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redox regulation systems.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call